| Identification | |
| Name: | Octanediamide,N1-hydroxy-N8-phenyl- |
| Synonyms: | Octanediamide,N-hydroxy-N'-phenyl- (9CI);N-Hydroxy-N'-phenyloctanediamide;SAHA;Suberoylanilide hydroxamic acid;Zolinza;CCRIS 8456;M344;SAHA cpd;Suberanilohydroxamic acid;UNII-58IFB293JI; |
| CAS: | 149647-78-9 |
| Molecular Formula: | C14H20N2O3 |
| Molecular Weight: | 264.3202 |
| InChI: | InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18) |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | °C |
| Boiling Point: | °Cat760mmHg |
| Density: | 1.174 g/cm3 |
| Refractive index: | 1.566 |
| Water Solubility: | Soluble in ethanol (0.25 mg/ml), DMSO & DMF (20 mg/ml) |
| Solubility: | Soluble in ethanol (0.25 mg/ml), DMSO & DMF (20 mg/ml) |
| Appearance: | White Crystalline Solid |
| Flash Point: | °C |
| Usage: |
Octanediamide,N1-hydroxy-N8-phenyl- (CAS NO.149647-78-9) is used as a powerful, selective, cell histone deacetylase inhibitors permeable (the HDAC). Display anti-angiogenic and vascular endothelial growth factor interference signal activity in human umbilical vein endothelial cells (endothelial cells). |
| Safety Data | |
 |
|
